Novel motif:95: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:02, 9 September 2013
name: | motif95_AGCGAGCTAGC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0033058 | directional locomotion | 7.809214e-10 |
GO:2000209 | regulation of anoikis | 6.531413e-9 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 1.778711e-8 |
GO:0042696 | menarche | 2.592152e-8 |
GO:0021759 | globus pallidus development | 2.721691e-8 |
GO:0060430 | lung saccule development | 4.415573e-8 |
GO:0097039 | protein linear polyubiquitination | 6.366894e-8 |
GO:0042538 | hyperosmotic salinity response | 1.770010e-7 |
GO:0010172 | embryonic body morphogenesis | 2.010459e-7 |
GO:0051365 | cellular response to potassium ion starvation | 5.606264e-7 |
GO:0006348 | chromatin silencing at telomere | 6.362752e-7 |
GO:0003108 | negative regulation of the force of heart contraction by chemical signal | 8.438815e-7 |
GO:0061084 | negative regulation of protein refolding | 1.286194e-6 |
GO:0006284 | base-excision repair | 1.599429e-6 |
GO:0031848 | protection from non-homologous end joining at telomere | 1.857533e-6 |
GO:0021986 | habenula development | 2.171918e-6 |
GO:0030262 | apoptotic nuclear change | 2.498104e-6 |
GO:0031627 | telomeric loop formation | 3.073622e-6 |
GO:0001774 | microglial cell activation | 3.556106e-6 |
GO:0060004 | reflex | 4.168960e-6 |
GO:2000210 | positive regulation of anoikis | 4.266174e-6 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 5.074060e-6 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 5.663767e-6 |
GO:0021506 | anterior neuropore closure | 6.093758e-6 |
GO:0033083 | regulation of immature T cell proliferation | 6.385618e-6 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 7.781863e-6 |
GO:0021895 | cerebral cortex neuron differentiation | 8.706485e-6 |
GO:0046599 | regulation of centriole replication | 8.720106e-6 |
GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway | 9.293691e-6 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 1.176134e-5 |
GO:0006353 | transcription termination, DNA-dependent | 1.177359e-5 |
GO:0006308 | DNA catabolic process | 1.194716e-5 |
GO:0060484 | lung-associated mesenchyme development | 1.449192e-5 |
GO:0072203 | cell proliferation involved in metanephros development | 1.657840e-5 |
GO:0006105 | succinate metabolic process | 1.702663e-5 |
GO:0018993 | somatic sex determination | 1.874896e-5 |
GO:0006370 | mRNA capping | 2.076708e-5 |
GO:0006208 | pyrimidine base catabolic process | 2.242810e-5 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 2.245022e-5 |
GO:0071105 | response to interleukin-11 | 2.266511e-5 |
GO:0023035 | CD40 signaling pathway | 2.266511e-5 |
GO:0009304 | tRNA transcription | 2.442715e-5 |
GO:0043543 | protein acylation | 2.575727e-5 |
GO:0042335 | cuticle development | 2.704348e-5 |
GO:0048808 | male genitalia morphogenesis | 2.740763e-5 |
GO:0021513 | spinal cord dorsal/ventral patterning | 2.777133e-5 |
GO:0010509 | polyamine homeostasis | 2.923447e-5 |
GO:0006363 | termination of RNA polymerase I transcription | 3.164263e-5 |
GO:0043973 | histone H3-K4 acetylation | 3.457829e-5 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 3.457829e-5 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 3.457829e-5 |
GO:0051647 | nucleus localization | 3.699963e-5 |
GO:0006538 | glutamate catabolic process | 3.743069e-5 |
GO:0046604 | positive regulation of mitotic centrosome separation | 3.820394e-5 |
GO:0043923 | positive regulation by host of viral transcription | 3.953435e-5 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 4.102011e-5 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 4.274472e-5 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 4.350508e-5 |
GO:0048339 | paraxial mesoderm development | 4.765794e-5 |
GO:0046605 | regulation of centrosome cycle | 4.778844e-5 |
GO:0014040 | positive regulation of Schwann cell differentiation | 4.780599e-5 |
GO:0015789 | UDP-N-acetylgalactosamine transport | 4.805709e-5 |
GO:0015787 | UDP-glucuronic acid transport | 4.805709e-5 |
GO:0018393 | internal peptidyl-lysine acetylation | 5.296787e-5 |
GO:0018394 | peptidyl-lysine acetylation | 5.485352e-5 |
GO:0035026 | leading edge cell differentiation | 5.621695e-5 |
GO:0051584 | regulation of dopamine uptake | 5.871243e-5 |
GO:0070170 | regulation of tooth mineralization | 6.656520e-5 |
GO:0006289 | nucleotide-excision repair | 6.729853e-5 |
GO:0072333 | signal transduction by p53 class mediator resulting in induction of anoikis | 7.605516e-5 |
GO:0072136 | metanephric mesenchymal cell proliferation involved in metanephros development | 7.605516e-5 |
GO:0048291 | isotype switching to IgG isotypes | 8.105519e-5 |
GO:0006844 | acyl carnitine transport | 8.105519e-5 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 8.105519e-5 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 8.105519e-5 |
GO:0002368 | B cell cytokine production | 8.105519e-5 |
GO:0006473 | protein acetylation | 8.273694e-5 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 8.756227e-5 |
GO:0043149 | stress fiber assembly | 9.019574e-5 |
GO:0021877 | forebrain neuron fate commitment | 9.086893e-5 |
GO:0050685 | positive regulation of mRNA processing | 9.188960e-5 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 9.635193e-5 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 9.635193e-5 |
GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation | 9.647833e-5 |
GO:0009452 | RNA capping | 9.662504e-5 |
GO:0016573 | histone acetylation | 9.958087e-5 |
GO:0000114 | regulation of transcription involved in G1 phase of mitotic cell cycle | 1.043175e-4 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 1.148793e-4 |
GO:0046113 | nucleobase catabolic process | 1.166262e-4 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 1.267011e-4 |
GO:0016570 | histone modification | 1.278879e-4 |
GO:0033590 | response to cobalamin | 1.294953e-4 |
GO:0006117 | acetaldehyde metabolic process | 1.294953e-4 |
GO:0048148 | behavioral response to cocaine | 1.313129e-4 |
GO:0006379 | mRNA cleavage | 1.390539e-4 |
GO:0060596 | mammary placode formation | 1.410852e-4 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 1.442311e-4 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 1.525878e-4 |
GO:0031860 | telomeric 3' overhang formation | 1.572937e-4 |
GO:0002031 | G-protein coupled receptor internalization | 1.626944e-4 |
GO:0048733 | sebaceous gland development | 1.665858e-4 |
GO:0043921 | modulation by host of viral transcription | 1.691563e-4 |
GO:0048663 | neuron fate commitment | 1.696899e-4 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 1.842598e-4 |
GO:0031440 | regulation of mRNA 3'-end processing | 1.871450e-4 |
GO:0021623 | oculomotor nerve formation | 1.927263e-4 |
GO:0003404 | optic vesicle morphogenesis | 1.927263e-4 |
GO:0003409 | optic cup structural organization | 1.927263e-4 |
GO:0007217 | tachykinin receptor signaling pathway | 1.997862e-4 |
GO:0050434 | positive regulation of viral transcription | 2.021618e-4 |
GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation | 2.038355e-4 |
GO:0016233 | telomere capping | 2.156149e-4 |
GO:0033262 | regulation of DNA replication involved in S phase | 2.174680e-4 |
GO:0003140 | determination of left/right asymmetry in lateral mesoderm | 2.189059e-4 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 2.209097e-4 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 2.312641e-4 |
GO:0018205 | peptidyl-lysine modification | 2.358771e-4 |
GO:0021511 | spinal cord patterning | 2.378000e-4 |
GO:0045647 | negative regulation of erythrocyte differentiation | 2.442459e-4 |
GO:0008033 | tRNA processing | 2.462924e-4 |
GO:0035308 | negative regulation of protein dephosphorylation | 2.567586e-4 |
GO:0035725 | sodium ion transmembrane transport | 2.601057e-4 |
GO:0072111 | cell proliferation involved in kidney development | 2.612840e-4 |
GO:0016569 | covalent chromatin modification | 2.613126e-4 |
GO:0042699 | follicle-stimulating hormone signaling pathway | 2.616579e-4 |
GO:0010452 | histone H3-K36 methylation | 2.616579e-4 |
GO:0070845 | polyubiquitinated misfolded protein transport | 2.662735e-4 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 2.693018e-4 |
GO:0000731 | DNA synthesis involved in DNA repair | 2.760633e-4 |
GO:0060178 | regulation of exocyst localization | 2.830188e-4 |
GO:0061157 | mRNA destabilization | 2.830188e-4 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 2.830188e-4 |
GO:0001928 | regulation of exocyst assembly | 2.830188e-4 |
GO:0006475 | internal protein amino acid acetylation | 2.873574e-4 |
GO:0071542 | dopaminergic neuron differentiation | 3.016596e-4 |
GO:0006540 | glutamate decarboxylation to succinate | 3.162618e-4 |
GO:0072093 | metanephric renal vesicle formation | 3.268864e-4 |
GO:0006369 | termination of RNA polymerase II transcription | 3.295501e-4 |
GO:0006405 | RNA export from nucleus | 3.496279e-4 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 3.519742e-4 |
GO:0002098 | tRNA wobble uridine modification | 3.521035e-4 |
GO:0034227 | tRNA thio-modification | 3.521035e-4 |
GO:0065002 | intracellular protein transmembrane transport | 3.855629e-4 |
GO:0032074 | negative regulation of nuclease activity | 3.883175e-4 |
GO:0022038 | corpus callosum development | 4.172165e-4 |
GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 4.260047e-4 |
GO:0007418 | ventral midline development | 4.314968e-4 |
GO:0006406 | mRNA export from nucleus | 4.489186e-4 |
GO:0033627 | cell adhesion mediated by integrin | 4.771317e-4 |
GO:0006972 | hyperosmotic response | 4.851975e-4 |
GO:2000617 | positive regulation of histone H3-K9 acetylation | 4.863640e-4 |
GO:2000620 | positive regulation of histone H4-K16 acetylation | 4.863640e-4 |
GO:0070512 | positive regulation of histone H4-K20 methylation | 4.863640e-4 |
GO:0060628 | regulation of ER to Golgi vesicle-mediated transport | 4.863640e-4 |
GO:0043400 | cortisol secretion | 4.938651e-4 |
GO:0070179 | D-serine biosynthetic process | 4.938651e-4 |
GO:0010571 | positive regulation of DNA replication involved in S phase | 4.938651e-4 |
GO:0042703 | menstruation | 5.096315e-4 |
GO:0019101 | female somatic sex determination | 5.096315e-4 |
GO:0032092 | positive regulation of protein binding | 5.167075e-4 |
GO:0046782 | regulation of viral transcription | 5.182672e-4 |
GO:0090239 | regulation of histone H4 acetylation | 5.230931e-4 |
GO:0043280 | positive regulation of caspase activity | 5.495666e-4 |
GO:0007626 | locomotory behavior | 5.502037e-4 |
GO:0006612 | protein targeting to membrane | 5.648230e-4 |
GO:0007228 | positive regulation of hh target transcription factor activity | 6.168534e-4 |
GO:0006206 | pyrimidine base metabolic process | 6.600930e-4 |
GO:0071281 | cellular response to iron ion | 6.733244e-4 |
GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 6.821057e-4 |
GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 6.821057e-4 |
GO:0030539 | male genitalia development | 6.849666e-4 |
GO:0043922 | negative regulation by host of viral transcription | 6.906940e-4 |
GO:0046607 | positive regulation of centrosome cycle | 6.934571e-4 |
GO:0070172 | positive regulation of tooth mineralization | 6.975532e-4 |
GO:0035304 | regulation of protein dephosphorylation | 7.100215e-4 |
GO:0070194 | synaptonemal complex disassembly | 7.469270e-4 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 7.469270e-4 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 7.577557e-4 |
GO:0071421 | manganese ion transmembrane transport | 7.577557e-4 |
GO:0060347 | heart trabecula formation | 7.621159e-4 |
GO:0006119 | oxidative phosphorylation | 7.623075e-4 |
GO:0003334 | keratinocyte development | 7.726721e-4 |
GO:0016539 | intein-mediated protein splicing | 7.751334e-4 |
GO:0006921 | cellular component disassembly involved in apoptosis | 7.976232e-4 |
GO:0030046 | parallel actin filament bundle assembly | 8.232592e-4 |
GO:0000022 | mitotic spindle elongation | 8.232592e-4 |
GO:0006360 | transcription from RNA polymerase I promoter | 8.297787e-4 |
GO:0007213 | muscarinic acetylcholine receptor signaling pathway | 8.383045e-4 |
GO:0016926 | protein desumoylation | 8.670830e-4 |
GO:0046600 | negative regulation of centriole replication | 9.172857e-4 |
GO:0001842 | neural fold formation | 9.696939e-4 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 9.961999e-4 |
GO:0043576 | regulation of respiratory gaseous exchange | 1.033394e-3 |
GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway | 1.062621e-3 |
GO:0072285 | mesenchymal to epithelial transition involved in metanephric renal vesicle formation | 1.062621e-3 |
GO:0060248 | detection of cell density by contact stimulus involved in contact inhibition | 1.062621e-3 |
GO:0009236 | cobalamin biosynthetic process | 1.062621e-3 |
GO:0007371 | ventral midline determination | 1.062621e-3 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 1.117091e-3 |
GO:0035306 | positive regulation of dephosphorylation | 1.120902e-3 |
GO:0061384 | heart trabecular morphogenesis | 1.141252e-3 |
GO:0071104 | response to interleukin-9 | 1.161283e-3 |
GO:0048178 | negative regulation of hepatocyte growth factor biosynthetic process | 1.177734e-3 |
GO:0090324 | negative regulation of oxidative phosphorylation | 1.181882e-3 |
GO:0010255 | glucose mediated signaling pathway | 1.181882e-3 |
GO:0050973 | detection of mechanical stimulus involved in equilibrioception | 1.181882e-3 |
GO:0019264 | glycine biosynthetic process from serine | 1.222480e-3 |
GO:0045819 | positive regulation of glycogen catabolic process | 1.248701e-3 |
GO:0006919 | activation of caspase activity | 1.256031e-3 |
GO:0060482 | lobar bronchus development | 1.264340e-3 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.267520e-3 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 1.269833e-3 |
GO:0022027 | interkinetic nuclear migration | 1.288717e-3 |
GO:0021559 | trigeminal nerve development | 1.294644e-3 |
GO:0052033 | pathogen-associated molecular pattern dependent induction by symbiont of host innate immunity | 1.301253e-3 |
GO:0070875 | positive regulation of glycogen metabolic process | 1.305809e-3 |
GO:0034470 | ncRNA processing | 1.344252e-3 |
GO:0060486 | Clara cell differentiation | 1.438139e-3 |
GO:0061056 | sclerotome development | 1.439806e-3 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 1.447427e-3 |
GO:0010225 | response to UV-C | 1.457379e-3 |
GO:0061098 | positive regulation of protein tyrosine kinase activity | 1.474737e-3 |
GO:0035196 | production of miRNAs involved in gene silencing by miRNA | 1.496655e-3 |
GO:0022417 | protein maturation by protein folding | 1.514938e-3 |
GO:0002074 | extraocular skeletal muscle development | 1.565456e-3 |
GO:0018202 | peptidyl-histidine modification | 1.595927e-3 |
GO:0090224 | regulation of spindle organization | 1.602369e-3 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 1.621288e-3 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 1.622695e-3 |
GO:0045078 | positive regulation of interferon-gamma biosynthetic process | 1.627019e-3 |
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 1.653693e-3 |
GO:0014038 | regulation of Schwann cell differentiation | 1.653693e-3 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 1.714259e-3 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 1.714259e-3 |
GO:0009589 | detection of UV | 1.714259e-3 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 1.714259e-3 |
GO:0070534 | protein K63-linked ubiquitination | 1.737206e-3 |
GO:0021837 | motogenic signaling involved in postnatal olfactory bulb interneuron migration | 1.750752e-3 |
GO:0060438 | trachea development | 1.772505e-3 |
GO:0030309 | poly-N-acetyllactosamine metabolic process | 1.844378e-3 |
GO:0050919 | negative chemotaxis | 1.898123e-3 |
GO:0021954 | central nervous system neuron development | 1.931881e-3 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 1.952339e-3 |
GO:0046602 | regulation of mitotic centrosome separation | 1.954146e-3 |
GO:0060685 | regulation of prostatic bud formation | 1.994549e-3 |
GO:0030238 | male sex determination | 2.082452e-3 |
GO:0071545 | inositol phosphate catabolic process | 2.083428e-3 |
GO:0010952 | positive regulation of peptidase activity | 2.116779e-3 |
GO:0070918 | production of small RNA involved in gene silencing by RNA | 2.149431e-3 |
GO:0035425 | autocrine signaling | 2.167916e-3 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 2.242964e-3 |
GO:0001302 | replicative cell aging | 2.307112e-3 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 2.309340e-3 |
GO:0021952 | central nervous system projection neuron axonogenesis | 2.314191e-3 |
GO:0051851 | modification by host of symbiont morphology or physiology | 2.323139e-3 |
GO:0048368 | lateral mesoderm development | 2.347406e-3 |
GO:0030237 | female sex determination | 2.394690e-3 |
GO:0021955 | central nervous system neuron axonogenesis | 2.401781e-3 |
GO:0060167 | regulation of adenosine receptor signaling pathway | 2.495875e-3 |
GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis | 2.495875e-3 |
GO:0070193 | synaptonemal complex organization | 2.496136e-3 |
GO:0030718 | germ-line stem cell maintenance | 2.534183e-3 |
GO:0048343 | paraxial mesodermal cell fate commitment | 2.550138e-3 |
GO:0010824 | regulation of centrosome duplication | 2.592169e-3 |
GO:0035305 | negative regulation of dephosphorylation | 2.592169e-3 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 2.642659e-3 |
GO:0046621 | negative regulation of organ growth | 2.658329e-3 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 2.683585e-3 |
GO:0018924 | mandelate metabolic process | 2.801898e-3 |
GO:0018105 | peptidyl-serine phosphorylation | 2.838753e-3 |
GO:0046092 | deoxycytidine metabolic process | 2.850780e-3 |
GO:0034241 | positive regulation of macrophage fusion | 2.850780e-3 |
GO:0033490 | cholesterol biosynthetic process via lathosterol | 2.850780e-3 |
GO:0007100 | mitotic centrosome separation | 2.850780e-3 |
GO:2000009 | negative regulation of protein localization at cell surface | 2.873275e-3 |
GO:0043456 | regulation of pentose-phosphate shunt | 2.873275e-3 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 2.954521e-3 |
GO:0060580 | ventral spinal cord interneuron fate determination | 2.954521e-3 |
GO:0006409 | tRNA export from nucleus | 2.954521e-3 |
GO:0003327 | type B pancreatic cell fate commitment | 2.954521e-3 |
GO:0002282 | microglial cell activation involved in immune response | 3.018505e-3 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 3.043006e-3 |
GO:0042551 | neuron maturation | 3.079750e-3 |
GO:0007196 | inhibition of adenylate cyclase activity by metabotropic glutamate receptor signaling pathway | 3.089755e-3 |
GO:0055089 | fatty acid homeostasis | 3.089755e-3 |
GO:0032536 | regulation of cell projection size | 3.133678e-3 |
GO:0050872 | white fat cell differentiation | 3.159722e-3 |
GO:0048524 | positive regulation of viral reproduction | 3.212610e-3 |
GO:0008344 | adult locomotory behavior | 3.225210e-3 |
GO:0050432 | catecholamine secretion | 3.287021e-3 |
GO:0015801 | aromatic amino acid transport | 3.403302e-3 |
GO:0021603 | cranial nerve formation | 3.438343e-3 |
GO:0034776 | response to histamine | 3.538031e-3 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 3.538031e-3 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 3.538031e-3 |
GO:0016046 | detection of fungus | 3.538031e-3 |
GO:0006313 | transposition, DNA-mediated | 3.538031e-3 |
GO:0045905 | positive regulation of translational termination | 3.558507e-3 |
GO:0045901 | positive regulation of translational elongation | 3.558507e-3 |
GO:0006452 | translational frameshifting | 3.558507e-3 |
GO:0044154 | histone H3-K14 acetylation | 3.558507e-3 |
GO:0060579 | ventral spinal cord interneuron fate commitment | 3.584173e-3 |
GO:0040023 | establishment of nucleus localization | 3.649103e-3 |
GO:0009262 | deoxyribonucleotide metabolic process | 3.687515e-3 |
GO:0070873 | regulation of glycogen metabolic process | 3.754239e-3 |
GO:0071359 | cellular response to dsRNA | 3.782662e-3 |
GO:0006610 | ribosomal protein import into nucleus | 3.793687e-3 |
GO:0050775 | positive regulation of dendrite morphogenesis | 3.834144e-3 |
GO:0072236 | metanephric loop of Henle development | 3.834929e-3 |
GO:0008635 | activation of caspase activity by cytochrome c | 3.905299e-3 |
GO:0072011 | glomerular endothelium development | 3.949943e-3 |
GO:0072144 | glomerular mesangial cell development | 3.949943e-3 |
GO:0071206 | establishment of protein localization to juxtaparanode region of axon | 3.949943e-3 |
GO:0060168 | positive regulation of adenosine receptor signaling pathway | 3.949943e-3 |
GO:0003151 | outflow tract morphogenesis | 3.985584e-3 |
GO:0043314 | negative regulation of neutrophil degranulation | 4.064205e-3 |
GO:0009264 | deoxyribonucleotide catabolic process | 4.075245e-3 |
GO:0021979 | hypothalamus cell differentiation | 4.108627e-3 |
GO:0015742 | alpha-ketoglutarate transport | 4.115555e-3 |
GO:0032897 | negative regulation of viral transcription | 4.207798e-3 |
GO:0045047 | protein targeting to ER | 4.238210e-3 |
GO:0060013 | righting reflex | 4.273611e-3 |
GO:0021853 | cerebral cortex GABAergic interneuron migration | 4.273611e-3 |
GO:0045200 | establishment of neuroblast polarity | 4.288433e-3 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 4.288433e-3 |
GO:0002082 | regulation of oxidative phosphorylation | 4.288433e-3 |
GO:0021819 | layer formation in cerebral cortex | 4.293182e-3 |
GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation | 4.314654e-3 |
GO:0042989 | sequestering of actin monomers | 4.318199e-3 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 4.500808e-3 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 4.636272e-3 |
GO:0032929 | negative regulation of superoxide anion generation | 4.916574e-3 |
GO:0046501 | protoporphyrinogen IX metabolic process | 4.916574e-3 |
GO:0072092 | ureteric bud invasion | 4.949287e-3 |
GO:0006545 | glycine biosynthetic process | 5.001834e-3 |
GO:0051532 | regulation of NFAT protein import into nucleus | 5.015582e-3 |
GO:0031297 | replication fork processing | 5.017978e-3 |
GO:0008589 | regulation of smoothened signaling pathway | 5.031545e-3 |
GO:0045737 | positive regulation of cyclin-dependent protein kinase activity | 5.073211e-3 |
GO:0031017 | exocrine pancreas development | 5.073211e-3 |
GO:0071539 | protein localization to centrosome | 5.144734e-3 |
GO:0042417 | dopamine metabolic process | 5.158908e-3 |
GO:0006481 | C-terminal protein methylation | 5.189213e-3 |
GO:0021953 | central nervous system neuron differentiation | 5.233690e-3 |
GO:0043097 | pyrimidine nucleoside salvage | 5.551923e-3 |
GO:0043983 | histone H4-K12 acetylation | 5.553924e-3 |
GO:0060534 | trachea cartilage development | 5.582148e-3 |
GO:0070671 | response to interleukin-12 | 5.638679e-3 |
GO:0043966 | histone H3 acetylation | 5.639387e-3 |
GO:0043174 | nucleoside salvage | 5.695427e-3 |
GO:0010676 | positive regulation of cellular carbohydrate metabolic process | 5.769831e-3 |
GO:0048340 | paraxial mesoderm morphogenesis | 5.795395e-3 |
GO:0051292 | nuclear pore complex assembly | 5.802019e-3 |
GO:0051660 | establishment of centrosome localization | 5.802019e-3 |
GO:0048561 | establishment of organ orientation | 5.802019e-3 |
GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 5.802019e-3 |
GO:0021540 | corpus callosum morphogenesis | 5.802019e-3 |
GO:0042694 | muscle cell fate specification | 5.802019e-3 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 5.865592e-3 |
GO:0031133 | regulation of axon diameter | 5.888032e-3 |
GO:0010907 | positive regulation of glucose metabolic process | 5.896937e-3 |
GO:0014044 | Schwann cell development | 5.933233e-3 |
GO:0071897 | DNA biosynthetic process | 5.934083e-3 |
GO:0072143 | mesangial cell development | 6.010750e-3 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 6.026247e-3 |
GO:0042780 | tRNA 3'-end processing | 6.045821e-3 |
GO:0006713 | glucocorticoid catabolic process | 6.045821e-3 |
GO:0035195 | gene silencing by miRNA | 6.119681e-3 |
GO:0010815 | bradykinin catabolic process | 6.126320e-3 |
GO:0051196 | regulation of coenzyme metabolic process | 6.129138e-3 |
GO:0060459 | left lung development | 6.130092e-3 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 6.186420e-3 |
GO:0021879 | forebrain neuron differentiation | 6.272484e-3 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 6.290889e-3 |
GO:0006563 | L-serine metabolic process | 6.325737e-3 |
GO:0010868 | negative regulation of triglyceride biosynthetic process | 6.341038e-3 |
GO:0048752 | semicircular canal morphogenesis | 6.508249e-3 |
GO:0046884 | follicle-stimulating hormone secretion | 6.635301e-3 |
GO:0032275 | luteinizing hormone secretion | 6.635301e-3 |
GO:0017004 | cytochrome complex assembly | 6.635301e-3 |
GO:0045875 | negative regulation of sister chromatid cohesion | 6.673766e-3 |
GO:0046620 | regulation of organ growth | 6.681454e-3 |
GO:0060399 | positive regulation of growth hormone receptor signaling pathway | 6.709210e-3 |
GO:0035552 | oxidative single-stranded DNA demethylation | 6.709210e-3 |
GO:0048242 | epinephrine secretion | 6.709210e-3 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 6.746699e-3 |
GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway | 6.887948e-3 |
GO:0043538 | regulation of actin phosphorylation | 6.906865e-3 |
GO:0008052 | sensory organ boundary specification | 6.906865e-3 |
GO:0014813 | satellite cell commitment | 7.064197e-3 |
GO:0051573 | negative regulation of histone H3-K9 methylation | 7.082349e-3 |
GO:0048859 | formation of anatomical boundary | 7.082349e-3 |
GO:0006244 | pyrimidine nucleotide catabolic process | 7.082349e-3 |
GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein | 7.082349e-3 |
GO:0021843 | substrate-independent telencephalic tangential interneuron migration | 7.082349e-3 |
GO:0001710 | mesodermal cell fate commitment | 7.191383e-3 |
GO:0051205 | protein insertion into membrane | 7.216793e-3 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 7.259094e-3 |
GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 7.278302e-3 |
GO:0060154 | cellular process regulating host cell cycle in response to virus | 7.282205e-3 |
GO:0031129 | inductive cell-cell signaling | 7.288886e-3 |
GO:0061097 | regulation of protein tyrosine kinase activity | 7.321805e-3 |
GO:0035194 | posttranscriptional gene silencing by RNA | 7.386793e-3 |
GO:0048332 | mesoderm morphogenesis | 7.585973e-3 |
GO:0003057 | regulation of the force of heart contraction by chemical signal | 7.616124e-3 |
GO:0006352 | transcription initiation, DNA-dependent | 7.649938e-3 |
GO:0060359 | response to ammonium ion | 7.670080e-3 |
GO:0045217 | cell-cell junction maintenance | 7.714046e-3 |
GO:0035435 | phosphate ion transmembrane transport | 7.798168e-3 |
GO:2000357 | negative regulation of kidney smooth muscle cell differentiation | 7.828084e-3 |
GO:2000063 | positive regulation of ureter smooth muscle cell differentiation | 7.828084e-3 |
GO:2000358 | positive regulation of kidney smooth muscle cell differentiation | 7.828084e-3 |
GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development | 7.828084e-3 |
GO:0007502 | digestive tract mesoderm development | 7.828084e-3 |
GO:0080125 | multicellular structure septum development | 7.828084e-3 |
GO:2000062 | negative regulation of ureter smooth muscle cell differentiation | 7.828084e-3 |
GO:0035511 | oxidative DNA demethylation | 7.828084e-3 |
GO:0014858 | positive regulation of skeletal muscle cell proliferation | 7.828084e-3 |
GO:0072592 | oxygen metabolic process | 7.828084e-3 |
GO:0046534 | positive regulation of photoreceptor cell differentiation | 7.828084e-3 |
GO:0060783 | mesenchymal smoothened signaling pathway involved in prostate gland development | 7.828084e-3 |
GO:0060782 | regulation of mesenchymal cell proliferation involved in prostate gland development | 7.828084e-3 |
GO:0009151 | purine deoxyribonucleotide metabolic process | 7.900250e-3 |
GO:0050886 | endocrine process | 7.960960e-3 |
GO:0014816 | satellite cell differentiation | 7.983470e-3 |
GO:0070309 | lens fiber cell morphogenesis | 8.101117e-3 |
GO:0006654 | phosphatidic acid biosynthetic process | 8.101117e-3 |
GO:0051702 | interaction with symbiont | 8.209787e-3 |
GO:0035137 | hindlimb morphogenesis | 8.212551e-3 |
GO:0071294 | cellular response to zinc ion | 8.299481e-3 |
GO:0035356 | cellular triglyceride homeostasis | 8.515927e-3 |
GO:0021997 | neural plate axis specification | 8.548159e-3 |
GO:0035470 | positive regulation of vascular wound healing | 8.548159e-3 |
GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter | 8.682927e-3 |
GO:0009450 | gamma-aminobutyric acid catabolic process | 8.770932e-3 |
GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway | 8.795647e-3 |
GO:0072529 | pyrimidine-containing compound catabolic process | 8.880513e-3 |
GO:0090303 | positive regulation of wound healing | 9.075297e-3 |
GO:0090230 | regulation of centromere complex assembly | 9.199566e-3 |
GO:0051318 | G1 phase | 9.235202e-3 |
GO:0003148 | outflow tract septum morphogenesis | 9.363401e-3 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 9.382226e-3 |
GO:0043628 | ncRNA 3'-end processing | 9.487864e-3 |
GO:0019230 | proprioception | 9.523539e-3 |
GO:0050652 | dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 9.571398e-3 |
GO:0034969 | histone arginine methylation | 9.647738e-3 |
GO:0021557 | oculomotor nerve development | 9.647738e-3 |
GO:0043967 | histone H4 acetylation | 9.688117e-3 |
GO:0045880 | positive regulation of smoothened signaling pathway | 1.000107e-2 |
GO:0070972 | protein localization in endoplasmic reticulum | 1.011731e-2 |
GO:0045084 | positive regulation of interleukin-12 biosynthetic process | 1.013219e-2 |
GO:0021871 | forebrain regionalization | 1.016188e-2 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 1.028671e-2 |
GO:0033692 | cellular polysaccharide biosynthetic process | 1.032824e-2 |
GO:0022011 | myelination in peripheral nervous system | 1.033394e-2 |
GO:0022601 | menstrual cycle phase | 1.036023e-2 |
GO:0051572 | negative regulation of histone H3-K4 methylation | 1.036535e-2 |
GO:0051567 | histone H3-K9 methylation | 1.036535e-2 |
GO:0016540 | protein autoprocessing | 1.036893e-2 |
GO:0007498 | mesoderm development | 1.042995e-2 |
GO:0014707 | branchiomeric skeletal muscle development | 1.047742e-2 |
GO:0048048 | embryonic eye morphogenesis | 1.059546e-2 |
GO:0043313 | regulation of neutrophil degranulation | 1.064073e-2 |
GO:2000773 | negative regulation of cellular senescence | 1.068943e-2 |
GO:0045039 | protein import into mitochondrial inner membrane | 1.068943e-2 |
GO:0006285 | base-excision repair, AP site formation | 1.068943e-2 |
GO:0043697 | cell dedifferentiation | 1.068943e-2 |
GO:0050779 | RNA destabilization | 1.069767e-2 |
GO:0019102 | male somatic sex determination | 1.071366e-2 |
GO:0060520 | activation of prostate induction by androgen receptor signaling pathway | 1.071366e-2 |
GO:0045720 | negative regulation of integrin biosynthetic process | 1.071366e-2 |
GO:0060480 | lung goblet cell differentiation | 1.074509e-2 |
GO:0032707 | negative regulation of interleukin-23 production | 1.074509e-2 |
GO:0051725 | protein de-ADP-ribosylation | 1.074509e-2 |
GO:0010675 | regulation of cellular carbohydrate metabolic process | 1.080730e-2 |
GO:0003309 | type B pancreatic cell differentiation | 1.084693e-2 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 1.088558e-2 |
GO:0034971 | histone H3-R17 methylation | 1.088558e-2 |
GO:0032900 | negative regulation of neurotrophin production | 1.090976e-2 |
GO:2000370 | positive regulation of clathrin-mediated endocytosis | 1.090976e-2 |
GO:0010760 | negative regulation of macrophage chemotaxis | 1.090976e-2 |
GO:0032244 | positive regulation of nucleoside transport | 1.090976e-2 |
GO:0048814 | regulation of dendrite morphogenesis | 1.096002e-2 |
GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep | 1.098766e-2 |
GO:0033566 | gamma-tubulin complex localization | 1.098766e-2 |
GO:0070256 | negative regulation of mucus secretion | 1.098766e-2 |
GO:0006384 | transcription initiation from RNA polymerase III promoter | 1.098766e-2 |
GO:0010722 | regulation of ferrochelatase activity | 1.098766e-2 |
GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.098766e-2 |
GO:0010430 | fatty acid omega-oxidation | 1.098766e-2 |
GO:0007130 | synaptonemal complex assembly | 1.101259e-2 |
GO:0042473 | outer ear morphogenesis | 1.105300e-2 |
GO:0048488 | synaptic vesicle endocytosis | 1.106887e-2 |
GO:0060592 | mammary gland formation | 1.107368e-2 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 1.121840e-2 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 1.123229e-2 |
GO:0070544 | histone H3-K36 demethylation | 1.126489e-2 |
GO:0032225 | regulation of synaptic transmission, dopaminergic | 1.145056e-2 |
GO:0071472 | cellular response to salt stress | 1.148807e-2 |
GO:0034442 | regulation of lipoprotein oxidation | 1.148807e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0010467 | gene expression | 6.717491e-10 |
GO:0090304 | nucleic acid metabolic process | 1.110372e-9 |
GO:0016070 | RNA metabolic process | 1.450240e-9 |
GO:0016072 | rRNA metabolic process | 5.941831e-9 |
GO:0006351 | transcription, DNA-dependent | 9.406280e-9 |
GO:0032774 | RNA biosynthetic process | 1.229146e-8 |
GO:0071422 | succinate transmembrane transport | 2.768741e-8 |
GO:0006139 | nucleobase-containing compound metabolic process | 2.858394e-8 |
GO:0070936 | protein K48-linked ubiquitination | 5.123335e-8 |
GO:0006364 | rRNA processing | 9.513938e-8 |
GO:0051252 | regulation of RNA metabolic process | 1.139211e-7 |
GO:0000154 | rRNA modification | 1.645688e-7 |
GO:0001579 | medium-chain fatty acid transport | 2.709436e-7 |
GO:0097022 | lymphocyte migration into lymph node | 3.057172e-7 |
GO:0072610 | interleukin-12 secretion | 3.057172e-7 |
GO:0010468 | regulation of gene expression | 3.284973e-7 |
GO:0031167 | rRNA methylation | 3.986902e-7 |
GO:0050775 | positive regulation of dendrite morphogenesis | 5.407371e-7 |
GO:0044260 | cellular macromolecule metabolic process | 6.091167e-7 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 6.427430e-7 |
GO:0006355 | regulation of transcription, DNA-dependent | 6.685277e-7 |
GO:0097026 | dendritic cell dendrite assembly | 6.718713e-7 |
GO:0045084 | positive regulation of interleukin-12 biosynthetic process | 9.668338e-7 |
GO:0034645 | cellular macromolecule biosynthetic process | 1.073909e-6 |
GO:0009059 | macromolecule biosynthetic process | 1.282814e-6 |
GO:0030031 | cell projection assembly | 1.748677e-6 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 2.355336e-6 |
GO:0010629 | negative regulation of gene expression | 3.497655e-6 |
GO:0070534 | protein K63-linked ubiquitination | 4.009649e-6 |
GO:0010556 | regulation of macromolecule biosynthetic process | 4.838100e-6 |
GO:0042760 | very long-chain fatty acid catabolic process | 5.759846e-6 |
GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 5.807153e-6 |
GO:0010498 | proteasomal protein catabolic process | 7.992750e-6 |
GO:0000738 | DNA catabolic process, exonucleolytic | 8.472131e-6 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 8.760552e-6 |
GO:0006281 | DNA repair | 1.026395e-5 |
GO:0051583 | dopamine uptake | 1.038794e-5 |
GO:0031508 | centromeric heterochromatin formation | 1.050550e-5 |
GO:0051171 | regulation of nitrogen compound metabolic process | 1.052056e-5 |
GO:0034660 | ncRNA metabolic process | 1.109766e-5 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 1.245606e-5 |
GO:0032119 | sequestering of zinc ion | 1.285364e-5 |
GO:0016568 | chromatin modification | 1.290787e-5 |
GO:0045948 | positive regulation of translational initiation | 1.336996e-5 |
GO:2000036 | regulation of stem cell maintenance | 1.410495e-5 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 1.646288e-5 |
GO:0060591 | chondroblast differentiation | 1.646288e-5 |
GO:0006325 | chromatin organization | 1.717049e-5 |
GO:0051099 | positive regulation of binding | 1.853314e-5 |
GO:0006434 | seryl-tRNA aminoacylation | 2.152589e-5 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 2.372566e-5 |
GO:2000412 | positive regulation of thymocyte migration | 2.586832e-5 |
GO:0002518 | lymphocyte chemotaxis across high endothelial venule | 2.586832e-5 |
GO:0042278 | purine nucleoside metabolic process | 2.760180e-5 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 2.786559e-5 |
GO:0001710 | mesodermal cell fate commitment | 2.865093e-5 |
GO:0051956 | negative regulation of amino acid transport | 2.920066e-5 |
GO:0032446 | protein modification by small protein conjugation | 2.974353e-5 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 2.997863e-5 |
GO:0034695 | response to prostaglandin E stimulus | 3.152750e-5 |
GO:0009452 | RNA capping | 3.371935e-5 |
GO:0061084 | negative regulation of protein refolding | 3.687416e-5 |
GO:0045075 | regulation of interleukin-12 biosynthetic process | 3.696310e-5 |
GO:0051253 | negative regulation of RNA metabolic process | 3.784231e-5 |
GO:0034641 | cellular nitrogen compound metabolic process | 4.125499e-5 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 4.127807e-5 |
GO:0045994 | positive regulation of translational initiation by iron | 4.127807e-5 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 4.127807e-5 |
GO:0002037 | negative regulation of L-glutamate transport | 4.127807e-5 |
GO:0030866 | cortical actin cytoskeleton organization | 4.247302e-5 |
GO:0042996 | regulation of Golgi to plasma membrane protein transport | 4.294032e-5 |
GO:0033590 | response to cobalamin | 4.294032e-5 |
GO:0032092 | positive regulation of protein binding | 4.526301e-5 |
GO:0014826 | vein smooth muscle contraction | 4.729525e-5 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 4.973434e-5 |
GO:0002036 | regulation of L-glutamate transport | 5.216931e-5 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 5.270560e-5 |
GO:0016567 | protein ubiquitination | 5.512368e-5 |
GO:0045624 | positive regulation of T-helper cell differentiation | 5.757490e-5 |
GO:0038007 | netrin-activated signaling pathway | 6.555305e-5 |
GO:2000772 | regulation of cellular senescence | 6.567401e-5 |
GO:0051953 | negative regulation of amine transport | 6.624643e-5 |
GO:0071843 | cellular component biogenesis at cellular level | 6.646174e-5 |
GO:0030035 | microspike assembly | 6.699149e-5 |
GO:0031323 | regulation of cellular metabolic process | 6.988292e-5 |
GO:0015939 | pantothenate metabolic process | 7.238955e-5 |
GO:0043632 | modification-dependent macromolecule catabolic process | 7.479487e-5 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7.620401e-5 |
GO:0046452 | dihydrofolate metabolic process | 7.865151e-5 |
GO:0071105 | response to interleukin-11 | 7.865151e-5 |
GO:0009119 | ribonucleoside metabolic process | 8.001729e-5 |
GO:0031128 | developmental induction | 8.067181e-5 |
GO:0031326 | regulation of cellular biosynthetic process | 8.246530e-5 |
GO:0046128 | purine ribonucleoside metabolic process | 8.419846e-5 |
GO:0007498 | mesoderm development | 8.726049e-5 |
GO:0031098 | stress-activated protein kinase signaling cascade | 8.830935e-5 |
GO:2000242 | negative regulation of reproductive process | 8.832867e-5 |
GO:0019941 | modification-dependent protein catabolic process | 9.324444e-5 |
GO:0046847 | filopodium assembly | 1.019488e-4 |
GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus | 1.054629e-4 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.117650e-4 |
GO:0006346 | methylation-dependent chromatin silencing | 1.213972e-4 |
GO:0010605 | negative regulation of macromolecule metabolic process | 1.249027e-4 |
GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 1.254695e-4 |
GO:0014040 | positive regulation of Schwann cell differentiation | 1.291776e-4 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 1.291776e-4 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 1.310687e-4 |
GO:0031327 | negative regulation of cellular biosynthetic process | 1.331242e-4 |
GO:0051276 | chromosome organization | 1.350158e-4 |
GO:0035674 | tricarboxylic acid transmembrane transport | 1.408803e-4 |
GO:0071104 | response to interleukin-9 | 1.408803e-4 |
GO:0031507 | heterochromatin formation | 1.453777e-4 |
GO:0045627 | positive regulation of T-helper 1 cell differentiation | 1.462473e-4 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 1.557460e-4 |
GO:0060235 | lens induction in camera-type eye | 1.598364e-4 |
GO:0042398 | cellular modified amino acid biosynthetic process | 1.625469e-4 |
GO:0030219 | megakaryocyte differentiation | 1.652528e-4 |
GO:0021549 | cerebellum development | 1.656680e-4 |
GO:0045905 | positive regulation of translational termination | 1.689457e-4 |
GO:0045901 | positive regulation of translational elongation | 1.689457e-4 |
GO:0006452 | translational frameshifting | 1.689457e-4 |
GO:0072093 | metanephric renal vesicle formation | 1.689524e-4 |
GO:0007254 | JNK cascade | 1.728146e-4 |
GO:0035195 | gene silencing by miRNA | 1.735582e-4 |
GO:0021983 | pituitary gland development | 1.846862e-4 |
GO:0048332 | mesoderm morphogenesis | 1.884009e-4 |
GO:0045168 | cell-cell signaling involved in cell fate commitment | 2.015035e-4 |
GO:0035725 | sodium ion transmembrane transport | 2.035090e-4 |
GO:0007141 | male meiosis I | 2.104168e-4 |
GO:0000729 | DNA double-strand break processing | 2.137891e-4 |
GO:0006807 | nitrogen compound metabolic process | 2.150843e-4 |
GO:0048333 | mesodermal cell differentiation | 2.304764e-4 |
GO:0051238 | sequestering of metal ion | 2.311475e-4 |
GO:0006556 | S-adenosylmethionine biosynthetic process | 2.311475e-4 |
GO:0032615 | interleukin-12 production | 2.311475e-4 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 2.487293e-4 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 2.489918e-4 |
GO:0034470 | ncRNA processing | 2.505494e-4 |
GO:0009890 | negative regulation of biosynthetic process | 2.609946e-4 |
GO:0009116 | nucleoside metabolic process | 2.697816e-4 |
GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.755096e-4 |
GO:0043524 | negative regulation of neuron apoptosis | 3.010576e-4 |
GO:0042254 | ribosome biogenesis | 3.044410e-4 |
GO:0035269 | protein O-linked mannosylation | 3.114114e-4 |
GO:0035194 | posttranscriptional gene silencing by RNA | 3.253416e-4 |
GO:0071233 | cellular response to leucine | 3.366054e-4 |
GO:0010070 | zygote asymmetric cell division | 3.366054e-4 |
GO:0006391 | transcription initiation from mitochondrial promoter | 3.442311e-4 |
GO:0006986 | response to unfolded protein | 3.606942e-4 |
GO:0022037 | metencephalon development | 3.630494e-4 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 3.695660e-4 |
GO:0071423 | malate transmembrane transport | 4.125133e-4 |
GO:2000682 | positive regulation of rubidium ion transport | 4.125133e-4 |
GO:0046491 | L-methylmalonyl-CoA metabolic process | 4.125133e-4 |
GO:2000688 | positive regulation of rubidium ion transmembrane transporter activity | 4.125133e-4 |
GO:0015709 | thiosulfate transport | 4.125133e-4 |
GO:0001682 | tRNA 5'-leader removal | 4.125133e-4 |
GO:0035826 | rubidium ion transport | 4.125133e-4 |
GO:0016078 | tRNA catabolic process | 4.125133e-4 |
GO:0032065 | cortical protein anchoring | 4.125133e-4 |
GO:0071281 | cellular response to iron ion | 4.298863e-4 |
GO:0046881 | positive regulation of follicle-stimulating hormone secretion | 4.347893e-4 |
GO:0009889 | regulation of biosynthetic process | 4.429898e-4 |
GO:0051254 | positive regulation of RNA metabolic process | 4.468445e-4 |
GO:2000774 | positive regulation of cellular senescence | 4.745116e-4 |
GO:0090402 | oncogene-induced senescence | 4.745116e-4 |
GO:0035986 | senescence-associated heterochromatin focus formation | 4.745116e-4 |
GO:0021696 | cerebellar cortex morphogenesis | 4.938489e-4 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 4.999660e-4 |
GO:0060216 | definitive hemopoiesis | 5.018852e-4 |
GO:0042473 | outer ear morphogenesis | 5.171738e-4 |
GO:0035645 | enteric smooth muscle cell differentiation | 5.258525e-4 |
GO:0007497 | posterior midgut development | 5.258525e-4 |
GO:0035553 | oxidative single-stranded RNA demethylation | 5.393389e-4 |
GO:0035461 | vitamin transmembrane transport | 5.393389e-4 |
GO:0035520 | monoubiquitinated protein deubiquitination | 5.393389e-4 |
GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process | 5.457899e-4 |
GO:0034508 | centromere complex assembly | 5.496462e-4 |
GO:0070170 | regulation of tooth mineralization | 5.520492e-4 |
GO:0006449 | regulation of translational termination | 5.833679e-4 |
GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 5.833679e-4 |
GO:0046500 | S-adenosylmethionine metabolic process | 5.871505e-4 |
GO:0070647 | protein modification by small protein conjugation or removal | 6.126973e-4 |
GO:0034661 | ncRNA catabolic process | 6.154771e-4 |
GO:0001672 | regulation of chromatin assembly or disassembly | 6.170388e-4 |
GO:0050901 | leukocyte tethering or rolling | 6.238800e-4 |
GO:0015746 | citrate transport | 6.398406e-4 |
GO:0009147 | pyrimidine nucleoside triphosphate metabolic process | 6.559535e-4 |
GO:0015872 | dopamine transport | 6.559535e-4 |
GO:0001787 | natural killer cell proliferation | 6.592436e-4 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 6.656814e-4 |
GO:0060712 | spongiotrophoblast layer development | 6.924646e-4 |
GO:2000016 | negative regulation of determination of dorsal identity | 7.021696e-4 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 7.395417e-4 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 7.623305e-4 |
GO:0050862 | positive regulation of T cell receptor signaling pathway | 7.674479e-4 |
GO:0030865 | cortical cytoskeleton organization | 7.834879e-4 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 8.393674e-4 |
GO:0002407 | dendritic cell chemotaxis | 8.421421e-4 |
GO:0010216 | maintenance of DNA methylation | 8.465340e-4 |
GO:0060347 | heart trabecula formation | 8.521832e-4 |
GO:0042921 | glucocorticoid receptor signaling pathway | 8.521832e-4 |
GO:0033128 | negative regulation of histone phosphorylation | 8.876504e-4 |
GO:0043393 | regulation of protein binding | 9.099800e-4 |
GO:0045625 | regulation of T-helper 1 cell differentiation | 9.175687e-4 |
GO:0044257 | cellular protein catabolic process | 9.584739e-4 |
GO:0001570 | vasculogenesis | 9.736386e-4 |
GO:0070672 | response to interleukin-15 | 1.073188e-3 |
GO:0045869 | negative regulation of retroviral genome replication | 1.073188e-3 |
GO:0001771 | immunological synapse formation | 1.078864e-3 |
GO:0043523 | regulation of neuron apoptosis | 1.110163e-3 |
GO:0034589 | hydroxyproline transport | 1.110402e-3 |
GO:0015826 | threonine transport | 1.110402e-3 |
GO:0019509 | L-methionine salvage from methylthioadenosine | 1.110402e-3 |
GO:0008635 | activation of caspase activity by cytochrome c | 1.129160e-3 |
GO:0060375 | regulation of mast cell differentiation | 1.132633e-3 |
GO:0007412 | axon target recognition | 1.148671e-3 |
GO:0019348 | dolichol metabolic process | 1.148671e-3 |
GO:0030163 | protein catabolic process | 1.163528e-3 |
GO:0090303 | positive regulation of wound healing | 1.172690e-3 |
GO:0003404 | optic vesicle morphogenesis | 1.182538e-3 |
GO:0021623 | oculomotor nerve formation | 1.182538e-3 |
GO:0071803 | positive regulation of podosome assembly | 1.182538e-3 |
GO:0003409 | optic cup structural organization | 1.182538e-3 |
GO:0051098 | regulation of binding | 1.188797e-3 |
GO:0070997 | neuron death | 1.228258e-3 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 1.262823e-3 |
GO:0008625 | induction of apoptosis via death domain receptors | 1.265042e-3 |
GO:0061035 | regulation of cartilage development | 1.282617e-3 |
GO:0072134 | nephrogenic mesenchyme morphogenesis | 1.322878e-3 |
GO:0060379 | cardiac muscle cell myoblast differentiation | 1.322878e-3 |
GO:0010845 | positive regulation of reciprocal meiotic recombination | 1.322878e-3 |
GO:0031129 | inductive cell-cell signaling | 1.322878e-3 |
GO:0045123 | cellular extravasation | 1.336058e-3 |
GO:0061046 | regulation of branching involved in lung morphogenesis | 1.349500e-3 |
GO:0001707 | mesoderm formation | 1.390506e-3 |
GO:0072076 | nephrogenic mesenchyme development | 1.398422e-3 |
GO:0061364 | apoptosis involved in luteolysis | 1.398422e-3 |
GO:0045919 | positive regulation of cytolysis | 1.436789e-3 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 1.480444e-3 |
GO:0043457 | regulation of cellular respiration | 1.502573e-3 |
GO:2000736 | regulation of stem cell differentiation | 1.510358e-3 |
GO:0031958 | corticosteroid receptor signaling pathway | 1.544476e-3 |
GO:0070842 | aggresome assembly | 1.565720e-3 |
GO:0048935 | peripheral nervous system neuron development | 1.573484e-3 |
GO:0030202 | heparin metabolic process | 1.583961e-3 |
GO:0045738 | negative regulation of DNA repair | 1.583961e-3 |
GO:0072092 | ureteric bud invasion | 1.583961e-3 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 1.583961e-3 |
GO:0035988 | chondrocyte proliferation | 1.634130e-3 |
GO:2000685 | positive regulation of cellular response to X-ray | 1.634130e-3 |
GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining | 1.634130e-3 |
GO:2001038 | regulation of cellular response to drug | 1.634130e-3 |
GO:0035978 | histone H2A-S139 phosphorylation | 1.634130e-3 |
GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter | 1.634130e-3 |
GO:0006117 | acetaldehyde metabolic process | 1.634130e-3 |
GO:0003131 | mesodermal-endodermal cell signaling | 1.634130e-3 |
GO:0031052 | chromosome breakage | 1.634130e-3 |
GO:0060557 | positive regulation of vitamin D biosynthetic process | 1.635558e-3 |
GO:0045218 | zonula adherens maintenance | 1.635558e-3 |
GO:0033578 | protein glycosylation in Golgi | 1.635558e-3 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.635558e-3 |
GO:0032786 | positive regulation of transcription elongation, DNA-dependent | 1.683793e-3 |
GO:0032288 | myelin assembly | 1.785986e-3 |
GO:0071711 | basement membrane organization | 1.813674e-3 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 1.816364e-3 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 1.820615e-3 |
GO:0043973 | histone H3-K4 acetylation | 1.820615e-3 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 1.820615e-3 |
GO:0003017 | lymph circulation | 1.820615e-3 |
GO:0060686 | negative regulation of prostatic bud formation | 1.846539e-3 |
GO:0014741 | negative regulation of muscle hypertrophy | 1.846539e-3 |
GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway | 1.883624e-3 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 1.967873e-3 |
GO:0021559 | trigeminal nerve development | 1.981792e-3 |
GO:0015937 | coenzyme A biosynthetic process | 1.986845e-3 |
GO:0003338 | metanephros morphogenesis | 2.033792e-3 |
GO:0006342 | chromatin silencing | 2.057764e-3 |
GO:0060319 | primitive erythrocyte differentiation | 2.096891e-3 |
GO:0060992 | response to fungicide | 2.097810e-3 |
GO:0043949 | regulation of cAMP-mediated signaling | 2.105179e-3 |
GO:0016075 | rRNA catabolic process | 2.107711e-3 |
GO:0042245 | RNA repair | 2.121147e-3 |
GO:0021758 | putamen development | 2.121147e-3 |
GO:0021757 | caudate nucleus development | 2.121147e-3 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 2.202592e-3 |
GO:0000042 | protein targeting to Golgi | 2.202592e-3 |
GO:0006396 | RNA processing | 2.203885e-3 |
GO:0019673 | GDP-mannose metabolic process | 2.218353e-3 |
GO:0060255 | regulation of macromolecule metabolic process | 2.230847e-3 |
GO:0031999 | negative regulation of fatty acid beta-oxidation | 2.258966e-3 |
GO:0043353 | enucleate erythrocyte differentiation | 2.259307e-3 |
GO:0006268 | DNA unwinding involved in replication | 2.259307e-3 |
GO:0006165 | nucleoside diphosphate phosphorylation | 2.259307e-3 |
GO:0006228 | UTP biosynthetic process | 2.259307e-3 |
GO:0034227 | tRNA thio-modification | 2.278563e-3 |
GO:0002525 | acute inflammatory response to non-antigenic stimulus | 2.289015e-3 |
GO:0046670 | positive regulation of retinal cell programmed cell death | 2.289015e-3 |
GO:0045226 | extracellular polysaccharide biosynthetic process | 2.301525e-3 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 2.301525e-3 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 2.301525e-3 |
GO:0030514 | negative regulation of BMP signaling pathway | 2.326784e-3 |
GO:0006448 | regulation of translational elongation | 2.347586e-3 |
GO:0006241 | CTP biosynthetic process | 2.406114e-3 |
GO:0060996 | dendritic spine development | 2.429025e-3 |
GO:0090342 | regulation of cell aging | 2.501591e-3 |
GO:0060318 | definitive erythrocyte differentiation | 2.564138e-3 |
GO:0031324 | negative regulation of cellular metabolic process | 2.605726e-3 |
GO:0007288 | sperm axoneme assembly | 2.632610e-3 |
GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 2.653120e-3 |
GO:0035621 | ER to Golgi ceramide transport | 2.757008e-3 |
GO:0030902 | hindbrain development | 2.763518e-3 |
GO:0007127 | meiosis I | 2.838751e-3 |
GO:0045345 | positive regulation of MHC class I biosynthetic process | 2.845636e-3 |
GO:0071545 | inositol phosphate catabolic process | 2.897343e-3 |
GO:0010002 | cardioblast differentiation | 2.937744e-3 |
GO:0072355 | histone H3-T3 phosphorylation | 2.947210e-3 |
GO:0060821 | inactivation of X chromosome by DNA methylation | 2.947210e-3 |
GO:0019428 | allantoin biosynthetic process | 2.947210e-3 |
GO:0019858 | cytosine metabolic process | 2.947210e-3 |
GO:0008612 | peptidyl-lysine modification to hypusine | 2.962351e-3 |
GO:0002098 | tRNA wobble uridine modification | 2.962351e-3 |
GO:0006282 | regulation of DNA repair | 2.970412e-3 |
GO:0043922 | negative regulation by host of viral transcription | 3.017742e-3 |
GO:0035082 | axoneme assembly | 3.017742e-3 |
GO:0080090 | regulation of primary metabolic process | 3.032307e-3 |
GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 3.111781e-3 |
GO:0045071 | negative regulation of viral genome replication | 3.151486e-3 |
GO:0007257 | activation of JUN kinase activity | 3.285431e-3 |
GO:0010159 | specification of organ position | 3.319370e-3 |
GO:0006183 | GTP biosynthetic process | 3.319370e-3 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 3.354627e-3 |
GO:0006308 | DNA catabolic process | 3.364197e-3 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 3.409105e-3 |
GO:0061042 | vascular wound healing | 3.447365e-3 |
GO:0071298 | cellular response to L-ascorbic acid | 3.447365e-3 |
GO:0042335 | cuticle development | 3.447365e-3 |
GO:2000366 | positive regulation of STAT protein import into nucleus | 3.447365e-3 |
GO:0060587 | regulation of lipoprotein lipid oxidation | 3.447365e-3 |
GO:0015854 | guanine transport | 3.447365e-3 |
GO:0033686 | positive regulation of luteinizing hormone secretion | 3.447365e-3 |
GO:0035344 | hypoxanthine transport | 3.447365e-3 |
GO:0035364 | thymine transport | 3.447365e-3 |
GO:0015853 | adenine transport | 3.447365e-3 |
GO:0048525 | negative regulation of viral reproduction | 3.539287e-3 |
GO:2000195 | negative regulation of female gonad development | 3.582393e-3 |
GO:0030730 | sequestering of triglyceride | 3.582393e-3 |
GO:0032897 | negative regulation of viral transcription | 3.585912e-3 |
GO:0032252 | secretory granule localization | 3.713532e-3 |
GO:2000380 | regulation of mesoderm development | 3.729123e-3 |
GO:0061037 | negative regulation of cartilage development | 3.729123e-3 |
GO:0002921 | negative regulation of humoral immune response | 3.729123e-3 |
GO:0060419 | heart growth | 3.743332e-3 |
GO:0009451 | RNA modification | 3.749853e-3 |
GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing | 3.755498e-3 |
GO:0007140 | male meiosis | 3.869057e-3 |
GO:0010628 | positive regulation of gene expression | 3.869544e-3 |
GO:0016458 | gene silencing | 3.888432e-3 |
GO:0070172 | positive regulation of tooth mineralization | 3.896087e-3 |
GO:0007352 | zygotic specification of dorsal/ventral axis | 3.896087e-3 |
GO:0006471 | protein ADP-ribosylation | 3.936081e-3 |
GO:0032851 | positive regulation of Rab GTPase activity | 3.975936e-3 |
GO:0048846 | axon extension involved in axon guidance | 3.987685e-3 |
GO:0071316 | cellular response to nicotine | 4.123076e-3 |
GO:0035552 | oxidative single-stranded DNA demethylation | 4.172865e-3 |
GO:0031055 | chromatin remodeling at centromere | 4.172865e-3 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 4.184237e-3 |
GO:0060977 | coronary vasculature morphogenesis | 4.204338e-3 |
GO:0043921 | modulation by host of viral transcription | 4.210774e-3 |
GO:0010665 | regulation of cardiac muscle cell apoptosis | 4.345141e-3 |
GO:0007064 | mitotic sister chromatid cohesion | 4.357070e-3 |
GO:0090074 | negative regulation of protein homodimerization activity | 4.434629e-3 |
GO:0048343 | paraxial mesodermal cell fate commitment | 4.434629e-3 |
GO:0032313 | regulation of Rab GTPase activity | 4.448263e-3 |
GO:0009892 | negative regulation of metabolic process | 4.479517e-3 |
GO:0001835 | blastocyst hatching | 4.583788e-3 |
GO:0035966 | response to topologically incorrect protein | 4.616679e-3 |
GO:2000272 | negative regulation of receptor activity | 4.726710e-3 |
GO:0043170 | macromolecule metabolic process | 4.752981e-3 |
GO:0060612 | adipose tissue development | 4.791224e-3 |
GO:0045799 | positive regulation of chromatin assembly or disassembly | 4.811847e-3 |
GO:0060217 | hemangioblast cell differentiation | 4.811847e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 4.811847e-3 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 4.811847e-3 |
GO:0003241 | growth involved in heart morphogenesis | 4.811847e-3 |
GO:0006713 | glucocorticoid catabolic process | 4.811847e-3 |
GO:0032927 | positive regulation of activin receptor signaling pathway | 4.811847e-3 |
GO:0031503 | protein complex localization | 4.928277e-3 |
GO:0032364 | oxygen homeostasis | 4.991407e-3 |
GO:0000185 | activation of MAPKKK activity | 5.166031e-3 |
GO:0030510 | regulation of BMP signaling pathway | 5.210632e-3 |
GO:0021697 | cerebellar cortex formation | 5.210760e-3 |
GO:0051955 | regulation of amino acid transport | 5.278830e-3 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 5.440409e-3 |
GO:0060559 | positive regulation of calcidiol 1-monooxygenase activity | 5.502679e-3 |
GO:0000422 | mitochondrion degradation | 5.502679e-3 |
GO:0045647 | negative regulation of erythrocyte differentiation | 5.625730e-3 |
GO:0002649 | regulation of tolerance induction to self antigen | 5.644518e-3 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 5.717519e-3 |
GO:0000209 | protein polyubiquitination | 5.739310e-3 |
GO:0003108 | negative regulation of the force of heart contraction by chemical signal | 5.807169e-3 |
GO:0010312 | detoxification of zinc ion | 5.812795e-3 |
GO:0009755 | hormone-mediated signaling pathway | 5.820463e-3 |
GO:0015936 | coenzyme A metabolic process | 5.847623e-3 |
GO:0051798 | positive regulation of hair follicle development | 5.848687e-3 |
GO:0003100 | regulation of systemic arterial blood pressure by endothelin | 5.893246e-3 |
GO:0035481 | positive regulation of Notch signaling pathway involved in heart induction | 6.042017e-3 |
GO:0021528 | commissural neuron differentiation in spinal cord | 6.042017e-3 |
GO:0060975 | cardioblast migration to the midline involved in heart field formation | 6.042017e-3 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 6.042017e-3 |
GO:0003210 | cardiac atrium formation | 6.042017e-3 |
GO:0003236 | sinus venosus morphogenesis | 6.042017e-3 |
GO:0003259 | cardioblast anterior-lateral migration | 6.042017e-3 |
GO:0015811 | L-cystine transport | 6.183761e-3 |
GO:0006418 | tRNA aminoacylation for protein translation | 6.343506e-3 |
GO:0060754 | positive regulation of mast cell chemotaxis | 6.538169e-3 |
GO:0060911 | cardiac cell fate commitment | 6.636863e-3 |
GO:0033483 | gas homeostasis | 6.636863e-3 |
GO:0051103 | DNA ligation involved in DNA repair | 6.688313e-3 |
GO:0048640 | negative regulation of developmental growth | 6.732172e-3 |
GO:0072205 | metanephric collecting duct development | 6.780526e-3 |
GO:0003281 | ventricular septum development | 6.808905e-3 |
GO:0060556 | regulation of vitamin D biosynthetic process | 6.899480e-3 |
GO:0006338 | chromatin remodeling | 6.993249e-3 |
GO:0051533 | positive regulation of NFAT protein import into nucleus | 7.144841e-3 |
GO:2000194 | regulation of female gonad development | 7.256112e-3 |
GO:0045065 | cytotoxic T cell differentiation | 7.275587e-3 |
GO:0010614 | negative regulation of cardiac muscle hypertrophy | 7.275587e-3 |
GO:0035404 | histone-serine phosphorylation | 7.275587e-3 |
GO:0051321 | meiotic cell cycle | 7.424501e-3 |
GO:0006366 | transcription from RNA polymerase II promoter | 7.531372e-3 |
GO:0001963 | synaptic transmission, dopaminergic | 7.579955e-3 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 7.795711e-3 |
GO:0042659 | regulation of cell fate specification | 7.797720e-3 |
GO:0032342 | aldosterone biosynthetic process | 7.802392e-3 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 7.813143e-3 |
GO:0045814 | negative regulation of gene expression, epigenetic | 7.836554e-3 |
GO:0048671 | negative regulation of collateral sprouting | 7.884799e-3 |
GO:0072348 | sulfur compound transport | 7.884799e-3 |
GO:0032060 | bleb assembly | 7.884799e-3 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 7.887874e-3 |
GO:0060004 | reflex | 8.145416e-3 |
GO:0010724 | regulation of definitive erythrocyte differentiation | 8.173024e-3 |
GO:0006705 | mineralocorticoid biosynthetic process | 8.173024e-3 |
GO:0000395 | nuclear mRNA 5'-splice site recognition | 8.348041e-3 |
GO:0060921 | sinoatrial node cell differentiation | 8.368075e-3 |
GO:0006863 | purine base transport | 8.368075e-3 |
GO:0006513 | protein monoubiquitination | 8.470767e-3 |
GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis | 8.495904e-3 |
GO:0072198 | mesenchymal cell proliferation involved in ureter development | 8.607322e-3 |
GO:0072192 | ureter epithelial cell differentiation | 8.607322e-3 |
GO:0072200 | negative regulation of mesenchymal cell proliferation involved in ureter development | 8.607322e-3 |
GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development | 8.607322e-3 |
GO:2000007 | negative regulation of metanephric comma-shaped body morphogenesis | 8.607322e-3 |
GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis | 8.607322e-3 |
GO:2000005 | negative regulation of metanephric S-shaped body morphogenesis | 8.607322e-3 |
GO:0090194 | negative regulation of glomerulus development | 8.607322e-3 |
GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis | 8.607322e-3 |
GO:0072101 | specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway | 8.607322e-3 |
GO:0060502 | epithelial cell proliferation involved in lung morphogenesis | 8.607322e-3 |
GO:0072097 | negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway | 8.607322e-3 |
GO:0048392 | intermediate mesodermal cell differentiation | 8.607322e-3 |
GO:0007500 | mesodermal cell fate determination | 8.607322e-3 |
GO:0060503 | bud dilation involved in lung branching | 8.607322e-3 |
GO:0055020 | positive regulation of cardiac muscle fiber development | 8.607322e-3 |
GO:0071893 | BMP signaling pathway involved in nephric duct formation | 8.607322e-3 |
GO:0061155 | pulmonary artery endothelial tube morphogenesis | 8.607322e-3 |
GO:0061151 | BMP signaling pathway involved in renal system segmentation | 8.607322e-3 |
GO:0061149 | BMP signaling pathway involved in ureter morphogenesis | 8.607322e-3 |
GO:0009108 | coenzyme biosynthetic process | 8.611906e-3 |
GO:0001869 | negative regulation of complement activation, lectin pathway | 8.683831e-3 |
GO:2000737 | negative regulation of stem cell differentiation | 8.683831e-3 |
GO:0032915 | positive regulation of transforming growth factor beta2 production | 8.683831e-3 |
GO:0030201 | heparan sulfate proteoglycan metabolic process | 8.724257e-3 |
GO:0060033 | anatomical structure regression | 8.863781e-3 |
GO:2000779 | regulation of double-strand break repair | 8.959379e-3 |
GO:0007525 | somatic muscle development | 8.971248e-3 |
GO:0048246 | macrophage chemotaxis | 8.971248e-3 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 8.988815e-3 |
GO:0042384 | cilium assembly | 8.994642e-3 |
GO:0043526 | neuroprotection | 9.156005e-3 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 9.170176e-3 |
GO:0032508 | DNA duplex unwinding | 9.170176e-3 |
GO:0043484 | regulation of RNA splicing | 9.174593e-3 |
GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity | 9.286458e-3 |
GO:0007369 | gastrulation | 9.543507e-3 |
GO:0001816 | cytokine production | 9.555936e-3 |
GO:0070989 | oxidative demethylation | 9.614207e-3 |
GO:0021603 | cranial nerve formation | 9.614207e-3 |
GO:0070584 | mitochondrion morphogenesis | 1.007425e-2 |
GO:0060038 | cardiac muscle cell proliferation | 1.012832e-2 |
GO:0071459 | protein localization to chromosome, centromeric region | 1.013768e-2 |
GO:0070194 | synaptonemal complex disassembly | 1.017755e-2 |
GO:0014063 | negative regulation of serotonin secretion | 1.017755e-2 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 1.021330e-2 |
GO:0035511 | oxidative DNA demethylation | 1.021330e-2 |
GO:0003156 | regulation of organ formation | 1.030168e-2 |
GO:0015851 | nucleobase transport | 1.039342e-2 |
GO:0007619 | courtship behavior | 1.039342e-2 |
GO:0034067 | protein localization in Golgi apparatus | 1.042034e-2 |